Figure & Data

References

Citations

Citations to this article as recorded by  

• Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
  Shashi Gujar, Jonathan G. Pol, Vishnupriyan Kumar, Manuela Lizarralde-Guerrero, Prathyusha Konda, Guido Kroemer, John C. Bell
  Nature Protocols.2024; 19(9): 2540.     CrossRef
• A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells
  Yanrong Zhou, Qianpeng Wang, Qi Ying, Xiaomei Zhang, Ting Ye, Kan Chen, Gongchu Li
  Marine Drugs.2023; 21(2): 77.     CrossRef
• Poxvirus-driven human diseases and emerging therapeutics
  Kritika Srinivasan Rajsri, Mana Rao
  Therapeutic Advances in Infectious Disease.2022;[Epub]     CrossRef
• The O H system: A panorama view of the PPV-host interaction
  Yongzhong Yu, Zhengxing Lian, Yudong Cui
  Infection, Genetics and Evolution.2022; 98: 105220.     CrossRef
• Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice
  Hajime Kurosaki, Motomu Nakatake, Teruhisa Sakamoto, Nozomi Kuwano, Masato Yamane, Kenta Ishii, Yoshiyuki Fujiwara, Takafumi Nakamura
  Cells.2021; 10(5): 985.     CrossRef
• Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo
  Xue Wang, Ningning Zhou, Tingting Liu, Xiaoyuan Jia, Ting Ye, Kan Chen, Gongchu Li
  Marine Drugs.2021; 19(6): 292.     CrossRef
• Novel Oncolytic Virus Armed with Cancer Suicide Gene and Normal Vasculogenic Gene for Improved Anti-Tumor Activity
  Su-Nam Jeong, So Young Yoo
  Cancers.2020; 12(5): 1070.     CrossRef
• Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status
  Yuhui Zhang, Zhuoming Liu
  Current Pharmaceutical Design.2020; 25(40): 4251.     CrossRef
• Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS–STING signalling
  James B. Eaglesham, Youdong Pan, Thomas S. Kupper, Philip J. Kranzusch
  Nature.2019; 566(7743): 259.     CrossRef
• Targeted therapy of human glioblastoma combining the oncolytic properties of parvovirus H-1 and attenuated strains of the vaccinia virus
  A. V. Tkacheva, G. F. Sivolobova, A. A. Grazhdantseva, O. B. Shevelev, I. A. Razumov, E. L. Zavjalov, V. B. Loktev, G. V. Kochneva
  Molecular Genetics Microbiology and Virology (Russian version).2019; 37(2): 83.     CrossRef
• Poxvirus oncolytic virotherapy
  Lino E. Torres-Domínguez, Grant McFadden
  Expert Opinion on Biological Therapy.2019; 19(6): 561.     CrossRef
• Targeted Therapy of Human Glioblastoma Combining the Oncolytic Properties of Parvovirus H-1 and Attenuated Strains of the Vaccinia Virus
  A. V. Tkacheva, G. F. Sivolobova, A. A. Grazhdantseva, O. B. Shevelev, I. A. Razumov, E. L. Zavjalov, V. B. Loktev, G. V. Kochneva
  Molecular Genetics, Microbiology and Virology.2019; 34(2): 140.     CrossRef
• Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines
  Edmund K. Moon, Liang-Chuan S. Wang, Kheng Bekdache, Rachel C. Lynn, Albert Lo, Stephen H. Thorne, Steven M. Albelda
  OncoImmunology.2018; 7(3): e1395997.     CrossRef
• Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer
  Michael White, Andrew Freistaedter, Gwendolyn J. B. Jones, Emmanuel Zervos, Rachel L. Roper, Aamir Ahmad
  PLOS ONE.2018; 13(2): e0193131.     CrossRef
• Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol
  Rutger David Luteijn, Ingo Drexler, Geoffrey L. Smith, Robert Jan Lebbink, Emmanuel J. H. J. Wiertz
  Journal of General Virology.2018; 99(6): 790.     CrossRef
• Oncolytic viruses: emerging options for the treatment of breast cancer
  Yogesh R. Suryawanshi, Tiantian Zhang, Karim Essani
  Medical Oncology.2017;[Epub]     CrossRef
• Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas
  Sangmin Kang, Jinjong Myoung
  Journal of Microbiology.2017; 55(5): 319.     CrossRef
• Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro
  Elena P. Goncharova, Julia S. Ruzhenkova, Ivan S. Petrov, Sergey N. Shchelkunov, Marina A. Zenkova
  Journal of Translational Medicine.2016;[Epub]     CrossRef
• Oncolytic virotherapy for urological cancers
  Zahid Delwar, Kaixin Zhang, Paul S. Rennie, William Jia
  Nature Reviews Urology.2016; 13(6): 334.     CrossRef
• Features of the Antitumor Effect of Vaccinia Virus Lister Strain
  Evgeniy Zonov, Galina Kochneva, Anastasiya Yunusova, Antonina Grazhdantseva, Vladimir Richter, Elena Ryabchikova
  Viruses.2016; 8(1): 20.     CrossRef
• Single-particle characterization of oncolytic vaccinia virus by flow virometry
  Vera A. Tang, Tyler M. Renner, Oliver Varette, Fabrice Le Boeuf, Jiahu Wang, Jean-Simon Diallo, John C. Bell, Marc-André Langlois
  Vaccine.2016; 34(42): 5082.     CrossRef
• Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors
  Sally Al Ali, Sara Baldanta, Mercedes Fernández-Escobar, Susana Guerra
  Viruses.2016; 8(5): 134.     CrossRef
• Naturally occurring reoviruses for human cancer therapy
  Manbok Kim
  BMB Reports.2015; 48(8): 454.     CrossRef
• Reoviral Oncotropism Against c-Myc Overexpressing HS 68 Cells
  Manbok Kim
  Journal of Bacteriology and Virology.2015; 45(2): 126.     CrossRef